Long-term efficacy and safety of hydrogen peroxide topical solution, 45% (w/w) in patients with common warts: Posttreatment results from the phase 2 WART 203 trial

Background: Verruca vulgaris (common warts) is a cutaneous manifestation of the human papillomavirus with no FDA-approved therapies available. We evaluated the long-term efficacy and safety of the proprietary, stabilized hydrogen peroxide topical solution, 45% (w/w) (HP45) in patients with common warts at 12 weeks after treatment completion.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research